Larimar Therapeutics, Inc. (LRMR)

NASDAQ: LRMR · IEX Real-Time Price · USD

7.71

-0.53 (-6.43%)

At close: Jul 2, 2024, 4:00 PM

8.09

+0.38 (4.93%)

After-hours: Jul 2, 2024, 7:26 PM EDT

Larimar Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2014
Market Capitalization	492	200	179	191	329	41	Upgrade
Market Cap Growth	147.05%	11.79%	-6.49%	-41.88%	692.51%	-77.27%	Upgrade
Enterprise Value	269	117	64	126	241	41	Upgrade
PE Ratio	-	-5.41	-5.05	-3.77	-7.74	-1.79	Upgrade
PB Ratio	2.13	2.44	1.61	2.97	3.67	-59.78	Upgrade
P/FCF Ratio	-13.27	-5.94	-6.46	-4.50	-7.78	-1.82	Upgrade
P/OCF Ratio	-13.33	-5.97	-6.48	-4.54	-7.79	-1.83	Upgrade
EV/EBITDA Ratio	-5.82	-3.19	-1.83	-2.50	-5.70	-1.76	Upgrade
EV/EBIT Ratio	-5.79	-3.17	-1.82	-2.48	-5.68	-1.75	Upgrade
EV/FCF Ratio	-7.15	-3.49	-2.33	-2.96	-5.71	-1.78	Upgrade
Debt / Equity Ratio	0.02	0.07	0.05	0.09	0.07	-0.14	Upgrade
Debt / EBITDA Ratio	-0.12	-0.15	-0.15	-0.12	-0.15	0.00	Upgrade
Debt / FCF Ratio	-0.15	-0.16	-0.20	-0.14	-0.15	0.00	Upgrade
Quick Ratio	17.81	9.27	11.19	8.08	10.45	0.17	Upgrade
Current Ratio	17.99	9.49	11.28	8.16	10.89	0.81	Upgrade
Return on Equity (ROE)	-35.70%	-38.80%	-42.00%	-71.60%	-47.80%	-43.30%	Upgrade
Return on Assets (ROA)	-32.20%	-34.30%	-35.90%	-59.50%	-40.70%	-29.60%	Upgrade
Return on Capital (ROIC)	-21.53%	-47.85%	-31.40%	-71.67%	-44.49%	3888.44%	Upgrade
Earnings Yield	-9.16%	-18.50%	-19.78%	-26.50%	-12.92%	-55.76%	Upgrade
FCF Yield	-7.42%	-16.83%	-15.48%	-22.21%	-12.85%	-54.92%	Upgrade
Buyback Yield / Dilution	-22.00%	-70.41%	-50.09%	-44.44%	-95.09%	-126.80%	Upgrade
Total Shareholder Return	-22.00%	-70.41%	-50.09%	-44.44%	-95.09%	-126.80%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).